Fɔ lɔng tɛm naw, pipul dɛn dɔn de si di sik dɛn we de ambɔg di at ɛn di blɔd (CVD) as man dɛn wɛlbɔdi prɔblɛm, bɔt stil na dɛn de mek uman dɛn day ɔlsay na di wɔl. Statistikin we dɛn jɔs dɔn mek sho se CVDs de mek 35% pan uman dɛn we de day ɔlsay na di wɔl , wit di nɔmba dɛn we de kɔntinyu fɔ go ɔp. Bɔt, di ɔwe ɛn di tin dɛn we dɛn fɔ du fɔ mek dɛn nɔ gɛt di sik fɔ uman dɛn at ɛn di blɔd wɛlbɔdi stil nɔ bɔku, we kin mek dɛn nɔ no di sik fayn, dɛn nɔ kin trit dɛn fayn, ɛn dɛn kin ebul fɔ mek dɛn nɔ day.
Ay Blɔd Prɛshɔn: Na Saylent Threat to Uman dɛn Wɛlbɔdi
Ay blɔd prɛshɔn, ɔ ay blɔd prɛshɔn, na di men tin we kin mek uman dɛn day ɛn dɛn at ɛn blɔd , ɛn na lɛk wan pat pan tri uman dɛn ɔlsay na di wɔl kin gɛt dis sik . I fayn fɔ no se, aypatɛnshɔn kin mek uman dɛn gɛt mɔ prɔblɛm pas man dɛn we gɛt di sem ej, ɛn dis kin mek dɛn gɛt at atak, dɛn nɔ kin no bɛtɛ bɛtɛ wan, ɛn dɛn kin gɛt dis maynia sik. So fɔ adrɛs di ay blɔd prɛshɔn impɔtant fɔ ridyus di risk fɔ uman dɛn we gɛt di sik we dɛn kɔl kadiovaskular sik ɛn di wan dɛn we de day.
Yunik Risk Fakta fɔ Uman dɛn
Apat frɔm di ay blɔd prɛshɔn, uman dɛn kin gɛt sɔm patikyula tin dɛn we kin mek dɛn gɛt sik dɛn we de ambɔg dɛn at ɛn blɔd:
· Dizayd we gɛt fɔ du wit bɛlɛ : Kɔndishɔn dɛm lɛk di sik we de mek uman gɛt bɛlɛ, we i gɛt dayabitis we i gɛt bɛlɛ, we i bɔn pikin bifo tɛm, we i nɔ gɛt bɛlɛ, ɛn we i bɔn pikin we dɔn day, kin rili mek uman dɛn gɛt lɔng tɛm risk fɔ di at ɛn blɔd.
· Awtoimyun εn inflammatory sik dεm : Uman dεm kin gεt sistεmik lupus εrythematosus εn rεumatoid arthritis pas man dεm, we kin kכntribyut to atεrosklεrosis εn korona maykrovaskular disfכnkshכn.
Fɔ fɛt di bad bad impak we aypatɛnshɔn kin du to uman dɛn, ɔganayzeshɔn dɛn lɛk di European Society of Cardiology de beg uman dɛn fɔ wach ɛn manej dɛn blɔd prɛshɔn aktif wan. Fɔ lɔng tɛm, ivin lɔw lɛvɛl haypatɛyshɔn kin mek yu gɛt mɔ sik dɛn na di at ɛn blɔd, pan ɔl we di blɔd prɛshɔn we de chenj kin rili denja fɔ uman dɛn.
Joytech’s Blood Pressure Monitors, we dɛn mek fɔ mɛzhɔ kɔrɛkt wan ɛn izi fɔ yuz , de gi uman dɛn impɔtant tul dɛn fɔ kɔnsistɛns blɔd prɛshɔn manejmɛnt ɛn fɔ ɛp dɛn kwik kwik wan.
Strateji fɔ mek pipul dɛn no bɔt di sik ɛn fɔ mek dɛn nɔ gɛt sik
Fɔ mek uman dɛn gɛt bɛtɛ wɛlbɔdi autkam fɔ di at ɛn di blɔd, dɛn nid fɔ tek akshɔn togɛda:
· Kɔmprɛhɛnsif data kɔlɛkshɔn : Rial-taym ɛn kɔrɛkt glob ɔl data bɔt uman dɛn kadiovaskular sik prɛvalɛns ɛn autkam impɔtant.
· Edukeshonal initiativs : Targeted programs fɔ tich uman dɛn bɔt dɛn yon kardiovaskul risk ɛn di tin dɛn we dɛn fɔ du fɔ mek dɛn nɔ gɛt dis sik.
· Ɛnjɔy risach ɛn tritmɛnt : Fɔ adrɛs di gap dɛm we de pan risach ɛn mɛdikal atɛnshɔn we dɛn de gi uman dɛn sik dɛm we gɛt fɔ du wit dɛn at ɛn blɔd.
Joytech stil de wok tranga wan fɔ advays uman dɛn wɛlbɔdi na di wɔl bay we dɛn de gi dɛn ay kwaliti wɛlbɔdi prɔdak ɛn savis dɛn we de gi uman dɛn pawa fɔ tek kɔntrol pan dɛn at ɛn blɔd wɛlbɔdi.
Fɔ Protɛkt Uman dɛn Wɛlbɔdi: Wan Globɛl Rispɔnsibiliti
Di sik dɛn we de ambɔg di at ɛn di blɔd stil de mek uman dɛn day ɔlsay na di wɔl , ɛn ay blɔd prɛshɔn, as di men tin we kin mek dɛn gɛt dis sik, nid fɔ mek dɛn pe atɛnshɔn to am wantɛm wantɛm. We wi mek pipul dɛn no bɔt di sik, mek dɛn ebul fɔ protɛkt dɛnsɛf, ɛn mek dɛn ebul fɔ mɛn dɛn wɛlbɔdi biznɛs fayn fayn wan, wi kin rili ridyus di sik dɛn we de apin ɛn di wan dɛn we de day pan uman dɛn we gɛt at ɛn blɔd, ɛn protɛkt dɛn wɛlbɔdi fɔ di jɛnɛreshɔn dɛn we de kam.
Fɔ gi uman dɛn pawa fɔ manej dɛn wɛlbɔdi na di at fɔ Joytech in mishɔn—bikɔs ɔl uman fɔ gɛt wɛlbɔdi tumara bambay.
